Germany's BioNTech on Monday lifted its 2025 revenue guidance after receiving initial payments from its new partner Bristol Myers Squibb in a cancer immunotherapy alliance that seeks to challenge ...

Pharmaceutical marketing has often been viewed through the lens of process and execution – campaigns, timelines, approvals.

For the second time in the space of a week, a big pharma group has served notice that it plans to charge the same price for one of its new medicines in the UK as it does in the US. AbbVie suggested ...

Global growth is expected to decline and downside risks to intensify as major policy shifts unfold After enduring a prolonged and unprecedented series of shocks, the global economy appeared to have ...

This year, BMS partnered to develop a PD-L1 and VEGF bispecific antibody and has acquired the rights to a new radiopharmaceutical asset.